Delivery Order SPE2DB22D1017-SPE2DB25FYPME
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,671.82 to AmerisourceBergen Drug Corp for RotaTeq Vaccine 2ML on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,746.10 to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine (2ML formulation) on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award status. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $4,150.39 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL) on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract utilizes firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of RotaTeq vaccine (2mL formulation) valued at $10,655.80. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award of the pharmaceutical product. The order is scheduled for ultimate completion on August 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,741.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 ML) with an ultimate completion date of August 25, 2025. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,331.36 to AmerisourceBergen Drug Corp for RotaTeq vaccine (2 mL formulation) on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of the vendor's extensive pharmaceutical supply relationship with DLA's Medical Supply Chain. The award specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,647.66 to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine in 2 milliliter units. This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award does not carry a set-aside designation, indicating it was competed among...
- The Defense Logistics Agency awarded a delivery order valued at $1,669.81 to AmerisourceBergen Drug Corp for RotaTeq Vaccine 2ml on August 20, 2025, with an ultimate completion date of August 21, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open procurement process. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's...
- The Defense Logistics Agency (DLA) awarded a $1,076.56 delivery order to AmerisourceBergen Drug Corp for RotaTeq vaccine (2mL) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract utilized no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued against AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,183.46 to AmerisourceBergen Drug Corp for RotaTeq vaccine (2mL) on July 25, 2025, with completion targeted for July 28, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate operations. This delivery order represents a single transaction...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPMEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,286.08 to AmerisourceBergen Drug Corp for the supply of RotaTeq vaccine in 2ML units. The contract, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, operates under firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a prime pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's substantial IDC vehicle enables it to supply a comprehensive range of pharmaceutical products and medical commodities, including vaccines, specialty medications, brand-name and generic drugs, and related medical supplies across multiple therapeutic domains to support defense health programs globally. This specific delivery order for RotaTeq vaccine fulfills immediate medical supply requirements within the broader framework of AmerisourceBergen's established relationship with DLA, demonstrating the company's role in maintaining critical vaccine availability for federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 8/29/25 |